@article{article, title  = {{865PDRANGE, a phase III, randomized, placebo-controlled, double-blind trial of ramucirumab (RAM) and docetaxel (DOC) in platinum-refractory urothelial carcinoma (UC): Overall survival results}},

 url = {{}},

 year = {{2018}},

 month = {{10}},

 author = {{Petrylak DP and Sternberg CN and Drakaki A and de Wit R and Nishiyama H and Necchi A and Castellano D and Bamias A and Chi KN and van der Heijden MS and Matsubara N et al}},

 doi = {{10.1093/annonc/mdy283.074}},

 volume = {{29}},

 journal = {{Annals of Oncology}},

 issue = {{suppl_8}},

 pages = {{viii304-viii305}},

 note = {{Accessed on 2024/12/22}}}